Mainstay Medical Announces Commercial Launch of ReActiv8® in Australia
DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced the commercial launch in Australia of ReActiv8®, its implantable neurostimulation system to treat chronic low back pain. “Launching ReActiv8, our...